Fundraising FoxNeuronity
1 known investors
Find your way into Neuronity
143 people in our graph can introduce you to the Neuronity team.
Sign up to see every warm intro you have to Neuronity
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Neuronity team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Neuronity develops therapies that enhance immune cell activity in the aging brain to prevent neurodegenerative disease progression. The company targets patients with age-related neurological conditions.
Founders & leadership
HJ
Hyun Joon LeeFounder · Chief Executive OfficerHyun Joon Lee holds a background in neuroscience with expertise in neurotrauma and neurodegenerative diseases, and has experience in preclinical research management, clinical endpoint identification, and biomarker development for therapeutic programs.
Investors · 1
Frequently asked questions
- What does Neuronity do?
- Neuronity develops therapies that enhance immune cell activity in the aging brain to prevent neurodegenerative disease progression. The company targets patients with age-related neurological conditions.
- Who founded Neuronity?
- Neuronity was founded by Hyun Joon Lee.
- Who are Neuronity's investors?
- Neuronity's investors include The Innovation Space.